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Background:  β-cell death due to endoplasmic reticulum (ER) stress has been regarded as an important pathogenic component 
of type 2 diabetes. The possibility has been suggested that sulfonylurea, currently being used as one of the main oral hypoglyce-
mic agents of type 2 diabetes, increases ER stress, which could lead to sulfonylurea failure. The authors of the present study ex-
amined ER stress of β-cells in a glucolipotoxic condition using glyburide (GB) in an environment mimicking type 2 diabetes. 
Methods:  Apoptosis was induced by adding various concentrations of GB (0.001 to 200 μM) to a glucolipotoxic condition using 
33 mM glucose, and the effects of varied concentrations of palmitate were evaluated via annexin V staining. The markers of ER 
stress and pro-apoptotic markers were assessed by Western blotting and semi-quantitative reverse transcription-polymerase 
chain reaction. Additionally, the anti-apoptotic markers were evaluated. 
Results:  Addition of any concentration of GB in 150 μM palmitate and 33 mM glucose did not increase apoptosis. The expres-
sion of phosphorylated eukaryotic initiation factor (eIF-2α) was increased and cleaved caspase 3 was decreased by adding GB to 
a glucolipotoxic condition. However, other ER stress-associated markers such as Bip-1, X-box binding protein-1, ATF-4 and C/
EBP-homologous protein transcription factor and anti-apoptotic markers phosphor-p85 phosphatidylinositol 3-kinase and 
phosphorylation of Akt did not change significantly. 
Conclusion:  GB did not show further deleterious effects on the degree of apoptosis or ER stress of INS-1 cells in a glucolipotox-
ic condition. Increased phosphorylation of eIF-2α may attenuate ER stress for adaptation to increased ER protein load. 
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INTRODUCTION
The incidence of type 2 diabetes has sharply increased. Type 2 
diabetes is characterized by insulin resistance and progressive 
decline in β-cell function. When β-cells do not compensate 
for insulin resistance and increased apoptosis, type 2 diabetes 
can develop [1]. Decreased β-cell function and mass are key 
factors in type 2 diabetes. Persistent hyperglycemia and elevat-
ed free fatty acids are suggested as a cause of β-cell failure and 
can occur via numerous mechanisms, including reactive oxy-
gen species (ROS), increased intracellular calcium and the ac-
tivation of endoplasmic reticulum (ER) stress. These processes 
have detrimental effects on β-cells by impairing insulin secre-
tion, decreasing insulin gene expression and inducing apopto-
sis [2,3].
  Pancreatic β-cells regulate insulin production and secretion 
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to control blood glucose levels. In hyperglycemia, β-cells secrete 
insulin, which activates proinsulin biosynthesis in the ER of 
β-cells [4]. Therefore, β-cells are highly specialized to handle 
the protein load within the ER. ER homeostasis, the dynamic 
balance between the ER protein load and the ER capacity to 
process this load, is important for proper protein folding. Dis-
ruption of ER homeostasis leads to accumulation of unfolded 
and misfolded proteins in the ER. This condition is referred to 
as ER stress [5,6] and has been postulated to result from in-
creased biosynthetic demand induced by chronic hyperglyce-
mia and elevated free fatty acids in the β-cells. This pathway is 
well understood in the context of the unfolded protein response 
(UPR), which relieves ER stress, restores homeostasis, and 
prevents cell death by inducing numerous downstream re-
sponses that decrease new protein arrival to the ER, increase 
the amount of ER chaperones to improve folding capacity, and 
increase a cell’s capacity to eliminate misfolded proteins. If un-
able to successfully perform these tasks, the UPR will trigger 
the apoptosis cascade [7]. The three primary modulators of 
the UPR are inositol requiring protein 1-α (IRE1-α), activat-
ing transcription factor 6 (ATF6), and protein kinase RNA 
(PRK)-like ER associated kinase (PERK) [8]. These sensors re-
main inactive via interaction with the ER chaperone BiP until 
activated by increased ER stress [9].
  Sulfonylurea drugs, which reduce blood glucose levels by 
stimulating insulin release from pancreatic β-cells [10], have 
been used in the treatment of type 2 diabetes since the early 
1950s. Despite the worldwide use of sulfonylureas, loss of β-cell 
mass and function has raised concern regarding the use of sul-
fonylureas for the treatment of type 2 diabetes mellitus. Stud-
ies have shown that sulfonylureas may induce apoptosis in 
β-cell lines and rodent islets [11], and sulfonylurea therapy 
failure is also very common in long-term treatment [12] though 
the mechanism is still unclear. However, some evidence has 
suggested that chronic use of sulfonylurea leads to ER stress in 
the β-cells, which finally causes exhaustion of β-cell function 
[13], and the decline in β-cell function causes the progressive 
deterioration of glycemic control. Qian et al. [14] suggested 
the hypothesis that sulfonylurea induces the loss of β-cell 
function and influences the natural history of the disease 
through acceleration of ER stress. The use of sulfonylureas for 
the treatment of type 2 diabetes mellitus may accelerate the 
loss of β-cell mass and function. Despite inconsistencies re-
garding types of sulfonylureas, previous results for these agents 
were generally negative [10-15]. A majority of the previous ex-
periments showed conflicting results regarding sulfonylureas 
in β-cells without stresses or with only glucotoxicity, conditions 
which are quite different from the internal conditions of dia-
betic patients. Thus, we aimed to assess the degree of apoptosis 
and ER stress of INS-1 cells using glyburide (GB) in a glucoli-
potoxic condition mimicking diabetes. 
METHODS
Cell culture
Rat insulinoma INS-1 cells were obtained from Yeungnam 
University in Korea and were maintained in RPMI1640 medi-
um containing 10% fetal bovine serum (FBS), 10 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
11 mM glucose, and 50 μM 2-mercaptoethanol. All experi-
ments were incubated at 37°C in 5% CO2 and were studied be-
tween the 30th and 40th passages.
Glucolipotoxic condition
INS-1 cells were plated in six-well plates at 5×10
4 cells per well 
at the appropriate conditions. The cells were incubated for 24 
hours in various concentrations of palmitate (100 to 500 μM) 
with 33 mM glucose, typically used as a high glucose concen-
tration [16]. To collect single cells, cells were treated with 
trypsin-ethylenediaminetetraacetic acid (EDTA) and centri-
fuged at 1,500 rpm for 5 minutes at 4°C. After aspirating the 
supernatants, cells were washed with 1 mL of annexin V bind-
ing solution (140 mM NaCl, 10 mM HEPES pH 7.4, 2.5 mM 
CaCl2) and centrifuged at 1,500 rpm for 5 minutes at 4°C. Su-
pernatants were removed, and 3 μL of annexin V-fluorescein 
isothiocyanate (FITC) and 10 μL of propidium iodide were 
added. After incubation for 15 minutes in the dark, 300 μL of 
fluorescence activated cell sorting (FACS) buffer (1% FBS, 0.1% 
NaN3) was added, and the sample was analyzed by FACSort 
(BectonDickinson, BD Bioscience, San Jose, CA, USA). After 
five repetitions, the concentration of palmitate producing 30% 
to 50% apoptosis in the INS-1 cells was chosen as the glucoli-
potoxic condition. 
GB effect on apoptosis in a glucolipotoxic condition 
The procedures to evaluate apoptosis were the same as those 
for achieving the glucolipotoxic condition except for the incu-
bating media. INS-1 cells plated in six-well plates were incu-
bated in various concentrations of GB (0.001 to 200 μM) for 
24 hours and then with medium containing 150 μM palmitate 482
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and 33 mM glucose for 24 hours. Apoptosis was assessed by 
annexin V staining and FACSort. The experiment was per-
formed in triplicate.
Change in markers representing ER stress and the anti-
apoptotic pathway by adding GB to a glucolipotoxic 
condition
The ER stress markers and anti-apoptotic defense were evalu-
ated using INS-1 cells incubated with 10 and 100 μM GB in a 
glucolipotoxic condition via semi-quantitative reverse tran-
scription-polymerase chain reaction (RT-PCR) and Western 
blotting. The ER stress markers such as Bip-1, ATF-4, X-box 
binding protein-1 (XBP-1) and C/EBP-homologous protein 
transcription factor (CHOP) were assessed by RT-PCR. Phos-
phorylated eukaryotic initiation factor (eIF)-2α, caspase 3, 
and cleaved caspase 3 were evaluated by Western blotting. Ad-
ditionally, the anti-apoptotic markers phosphor-p85 phospha-
tidylinositol 3-kinase (PI3K) and phosphorylation of Akt were 
also appraised by Western blotting. The experiment was per-
formed in triplicate.
Reverse transcription polymerase chain reaction (RT-PCR)
Total cellular RNA was isolated using Trizol reagent (Invitro-
gen, Carlsbad, CA, USA). cDNA was synthesized by PCR us-
ing primers of ER stress markers from a premix RT-PCR kit 
(Bioneer, Daejeon, Korea). The following primer sequences 
were used: ATF-4; forward, 5′-TCTGTATGAGCCCT-
GAGTCCTACCT-3′; reverse, 5′-GGTCATAAGGTTT-
GGGTCGAGAACCAC-3′, Bip-1; forward, 5′-GAGATT-
GTTCTGGTTGGCGGATCTACTC-3′; reverse, 5′-CCATAT-
GCTACAGCCTCATCTGGGTT-3′, CHOP; forward, 
5′-CCTGAAAGCAGAAACCGGTC-3′; reverse, 5′-CCT-
CATACCAGGCTTCCAGC-3′, XBP-1; forward, 5′-AAA-
CAGAGTAGCAGCACAGACTGC-3′;  reverse, 
5′-GGATCTCTAAGACTAGAGGCTTGGTG-3′, and GAP-
DH; forward, 5′-TCCCTCAAGATTGTCAGCAA-3′; reverse, 
5′-AGATCCACAACGGATACATT-3′. Amplification was 
performed under the following conditions using a MyCycler 
thermal cycler (Bio-Rad, Hercules, CA, USA): pre-denatur-
ation at 95°C for 2 minutes; denaturation at 95°C for 30 sec-
onds annealing at 40°C for 30 seconds; extension at 72°C for 30 
seconds, and final extension at 72°C for 7 minutes. After am-
plification, 5 μL of the PCR products were subjected to elec-
trophoresis on 1.5% agarose gels. The gels were visualized by a 
SL-20 DNA Image Visualizer (Seoulin, Seoul, Korea).
Western blotting
INS-1 cells were washed with phosphate buffered saline (PBS) 
and lysed in mammalian tissue lysis/extraction reagent in-
cluding protease inhibitors and sodium orthovanadate. Pro-
tein was quantified using the BCA protein assay kit with 1× 
sodium dodecyl sulfate (SDS) sample buffer (50 mM Tris pH 
6.8, 2% SDS, 10% glycerol, 50 mM DTT, and 0.01% bromo-
phenol blue). Proteins were separated via 12% SDS-polyacryl-
amide gel electrophoresis (PAGE), transferred onto a polyvi-
nylidene fluoride (PVDF) membrane, and immunoblotted 
with anti-PI3K (Tyr 458) (1:1,000), anti-total Akt (1:1,000), 
anti-phospho Akt (Ser 473) (1:1,000), anti-caspase 3 (1:1,000), 
anti-eIF-2α (1:1,000), anti-phosphoserine 51 eIF-2α (1:1,000), 
and anti-β-actin (1:1,000) at 4°C overnight. The secondary an-
tibody goat anti-rabbit conjugated alkaline phosphatase was 
applied for 1 hour at room temperature, and the membrane 
was developed using an AP-conjugated development kit (Bio-
Rad). Developed protein bands were quantified by the Multi 
Gauge V2.2 program.
RESULTS 
Glucolipotoxic condition
Apoptosis of INS-1 cells cultured in 33 mM glucose and 100-
500 μM concentrations of palmitate increased dose-depend-
ently. The concentration of palmitate constantly achieving 30-
50% apoptosis in repeated experiments was chosen as the glu-
colipotoxic condition. The medium containing 150 μM of pal-
mitate resulted in 42.6±10.52% apoptosis (Fig. 1).
GB effect on apoptosis in a glucolipotoxic condition
Addition of 0.001 to 200 μM GB in 150 μM palmitate and 33 
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Fig. 1.  Apoptosis in INS-1 cells after incubation for 24 hours 
in culture media with 33 mM glucose and various concentra-
tions of palmitate according to annexin V staining. Values are 
presented as mean±standard deviation of five repetitions.483
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mM glucose did not significantly induce apoptosis (Fig. 2). 
Rather, apoptosis tended to decrease in media containing 0.01 
μM GB compared to that in the glucolipotoxic condition, al-
though not significantly.
Changes in ER stress markers due to the addition of GB to 
a glucolipotoxic condition
Changes of the markers in the early cascade of ER stress ac-
cording to GB addition to a glucolipotoxic condition 
The ER stress markers Bip-1 (Fig. 3A), ATF-4 (Fig. 3B), XBP-1 
(Fig. 3C), and phosphorylated eIF-2α (Fig. 3D) increased in 
glucotoxic and glucolipotoxic conditions compared to the lev-
Fig. 2.  The effect on apoptosis of INS-1 cells at various con-
centrations of glyburide in a glucolipotoxic condition. Apop-
tosis was evaluated using annexin V staining. The experiments 
were performed in triplicate. Values are presented as mean± 
standard deviation and 
aP<0.05.
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Fig. 3.  Changes in endoplasmic reticulum stress markers with the addition of glyburide to a glucolipotoxic condition. Bip-1 (A), 
ATF-4 (B), and XBP-1 (C) were evaluated using reverse transcription-polymerase chain reaction. Phosphorylated eukaryotic 
initiation factor (eIF)-2α and eIF-2α were analyzed by Western blotting, and the phosphorylation rate was assessed (D). The ex-
periments were performed in triplicate. Values are presented as mean±standard deviation and 
aP<0.05 for results under a gluco-
lipotoxic condition.
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els observed in the normal glucose controls. The addition of 
GB into INS-1 cells in the glucolipotoxic condition did not 
significantly increase the expressions of these ER stress mark-
ers, and Bip-1 and ATF-4 tended to decrease with the addition 
of GB compared to the glucolipotoxic only condition, al-
though the change was not significant. In addition, phosphor-
ylation of eIF-2α showed an increase when GB was added to 
the glucolipotoxic condition. Conversely, according to the ear-
ly cascade of markers of ER stress used in the present study, 
the phosphorylation of eIF-2α showed a significant reduction 
after GB addition compared to the levels in the glucolipotoxic 
condition.
Changes in ER stress markers representing the apoptotic 
pathway initiated by the addition of GB to a glucolipotoxic 
condition 
Functional caspase 3 decreased and cleaved caspase 3 increased 
accordingly from control conditions to those of glucotoxicity 
and glucolipotoxicity (Fig. 4A and B). In other words, the 
cleaved caspase 3 form was increased compared to that of 
functional caspase 3. Although caspase 3 did not change due 
to the addition of GB to the glucolipotoxic condition, cleaved 
caspase 3 decreased significantly. Another pro-apoptotic mark-
er CHOP was not significantly affected by the addition of GB 
(Fig. 4C).
Changes in anti-apoptotic markers
The markers representing apoptotic stress, PI3K (Fig. 5A) and 
phosphorylated Akt (Fig. 5B), tended to decrease in a β-cell 
damaged state such as glucotoxicity or glucolipotoxicity. How-
ever, the markers did not show any differences with the addi-
tion of GB to a glucolipotoxic condition.
Fig. 4.  Changes in endoplasmic reticulum stress mark-
ers representing the pro-apoptotic pathway by adding 
glyburide to a glucolipotoxic condition. Functional cas-
pase 3 (A) and cleaved caspase 3 (B) were evaluated ac-
cording to Western blotting. CHOP (C) was assessed by 
reverse transcription-polymerase chain reaction. The 
experiments were performed in triplicate. Values are 
presented as mean±standard deviation and 
aP<0.05 for 
results under a glucolipotoxic condition.
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DISCUSSION
The term glucolipotoxicity has emerged after recognition that 
the alterations in intracellular lipid partitioning underlying the 
mechanisms of lipotoxicity are dependent upon elevated glu-
cose levels [17]. Prolonged exposure of isolated islets or insu-
lin-secreting cells to elevated levels of fatty acids induces the 
inhibition of glucose-stimulated insulin secretion (GSIS) [18, 
19], impairment of insulin gene expression [20], and induc-
tion of cell death by apoptosis [16,21-23]. Evidence for ER 
stress in islets from type 2 diabetics has been shown through 
an increase in ER chaperones and CHOP along with enlarged 
ER [24-26].
  Concern has been raised because studies have shown that 
sulfonylureas may induce β-cell apoptosis. In a recent study, 
β-cell apoptosis was induced by GB as well as the non-sulfo-
nylurea secretagogues repaglinide and nateglinide in isolated 
human islets [15]. Glyburide of 0.1 and 10 μM induced 2.09- 
and 2.46-fold increases in β-cell apoptosis, whereas repa-
glinide did not change the number of apoptotic β-cells. At low 
concentration, nateglinide did not induce β-cell apoptosis, al-
though a 1.49-fold increase in the number of apoptotic β-cells 
was observed at high concentrations. On the fourth day after 
exposure of the islets to secretagogues, β-cell apoptosis was 
apparent for all secretagogues.
  Additionally, another study using human islets assessed the 
insulin content, GSIS, islet cell apoptosis, and mRNA expres-
sion of insulin and glucose transporter-1 in isolated human is-
lets cultured in the presence of therapeutic concentrations of 
glimepiride (10 μmol/L), GB (10 μmol/L), or chlorpropamide 
(600 μmol/L) [10]. Insulin content decreased significantly af-
ter culture with all three sulfonylureas. Insulin responsiveness 
to glucose was preserved in islets incubated with glimepiride 
but not when islets were pre-incubated with GB or chlorprop-
amide.
  Several studies have reported that chronic use of sulfonyl-
ureas increases the level of proinsulin (misfolded product of 
ER in β-cells) in the plasma of type 2 diabetes, indicating dis-
equilibrium between ER load and folding capacity in β-cells 
[27,28]. Previous studies of β-cell apoptosis due to sulfonyl-
urea were conducted at normal glucose concentrations or glu-
cotoxic conditions in each cell line. However, the present study 
was conducted under a glucolipotoxic condition, which ele-
vated ER stress, mimicking the internal environment of dia-
betic patients. Interestingly, apoptosis did not increase after 
addition of GB, a second-generation sulfonylurea, to create a 
glucolipotoxic condition (Fig. 2). Instead, apoptosis tended to 
decrease in media containing 0.01 μM GB compared to that in 
a glucolipotoxic condition, although not significantly. One 
probable hypothesis for this occurrence is the binary switch in 
ER stress [29]. The UPR regulates both adaptive and apoptotic 
effectors. The balance between the effectors depends on the 
nature of the ER stress, whether tolerable or intolerable. On 
sensing ER stress, IRE1 undergoes oligomerization and trans-
Fig. 5.  Changes in PI3K (A) and phosphorylated Akt (B), markers representing anti-apoptotic defense, due to the addition of 
glyburide to a glucolipotoxic condition. The experiments were performed in triplicate. Values are presented as mean±standard 
deviation. 
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autophosphorylation to activate its endoribonuclease domain. 
Activated IRE1 cleaves an intron from the mRNA encoding 
XBP-1. The spliced variant of XBP1 mRNA encodes a tran-
scriptional activator for several UPR genes including chaper-
ones, protein folding catalysts, and ER-associated degradation 
(ERAD) components. In addition to homeostatic functions, 
IRE1 also regulates apoptotic effectors. In the presence of un-
resolvable ER stress, IRE1 activates JNK through ASK1 and 
elicits apoptosis. This pathway has been shown to block the 
function of the anti-apoptotic Bcl-2 via phosphorylation, thus 
causing apoptosis in β-cells. IRE1 is also involved in the decay 
of the mRNAs encoding ER homeostatic proteins, including 
PDI, and BiP. Thus, IRE1 may be a major determinant of cell 
death. Under tolerable ER stress conditions, the UPR promotes 
β-cell survival. In contrast, under unresolvable ER stress con-
ditions, the UPR induces β-cell death. Cells are exposed to 
physiological conditions that induce tolerable ER stress. Un-
der ER stress conditions, the UPR can restore ER homeostasis 
to promote cell survival. Tight control of eIF2α phosphoryla-
tion is critical to ensure proper adaptation to increases in ER 
protein load and to promote β-cell survival [30-33]. Insulin 
biosynthesis stimulated by high glucose is markedly enhanced 
in PERK knockout mice as compared with that in control mice 
[30]. As a consequence, PERK knockout mice develop diabe-
tes because of ER stress-mediated β-cell death. IRE1 is also ac-
tivated under transient high glucose conditions. Acute IRE1 
activation is required for proinsulin biosynthesis and perhaps 
enhancement of the ER proinsulin folding capacity [34]. The 
above-mentioned observations demonstrate that cells utilize 
the UPR in order to handle physiological disruptions of ER 
homeostasis to promote survival.
  In the present study, most of the ER stress markers did not 
show significant differences after GB addition. Nevertheless, 
eIF2α phosphorylation was increased by GB, and proapoptot-
ic CHOP tended to decrease, although not significantly. The 
data support the possibility that GB acts in agreement with an 
adaptive pathway of ER stress.
  The United Kingdom Prospective Diabetes Study (UKPDS) 
determined that the loss of β-cell function was not unique to 
sulfonylureas but occurred at the same rate of decline in type 2 
diabetic patients on metformin or those on conventional treat-
ment [35]. This indicates that the use of sulfonylureas in type 2 
diabetes may not be the direct cause of secondary β-cell fail-
ure. 
  The present study has several limitations regarding the cell 
line, type of sulfonylurea, and utilization of only in vitro data, 
as well as lack of a more detailed mechanism. Only a single 
β-cell line, INS-1, was used. To support the results, further 
studies will be needed using various cell lines and primary cell 
cultures of rodent and humans. Additionally, among the sulfo-
nylureas, only GB was used. Several studies demonstrated that 
recently developed sulfonylureas did not increase apoptosis 
[10,36]. If GB does not induce apoptosis, other sulfonylureas 
currently being used and for which better data have been col-
lected could be presumed to produce more favorable results; 
the authors intend to evaluate these recently developed sulfo-
nylureas. Another limitation of the present study is the inclu-
sion of only in vitro experiments. Although animal models of 
type 2 diabetes may represent internal glucolipotoxic condi-
tions, the ability to measure the degree of glucolipotoxicity is 
difficult, and in vivo studies cannot rule out the possibility of 
interaction with another parameter. However, a well-designed 
in vivo experiment will be needed to confirm the results. In 
addition, the present study cannot explain a more detailed 
mechanism. Recently, several studies have reported that anti-
apoptotic markers such as apoptosis antagonizing transcrip-
tion factor (AATF) [37] and PI3K/Akt pathway [38] are asso-
ciated with ER stress. In the present study, the induction of 
apoptosis by the addition of GB to a glucolipotixic condition 
did not show significant changes despite a decreasing tenden-
cy. Therefore, PI3K and Akt did not show direct correlation 
with an anti-apoptotic effect, although the pathway did not 
produce any harmful effects.
  GB did not show further deleterious effects on the degree of 
apoptosis or ER stress of INS-1 cells in a glucolipotoxic condi-
tion. Increased phosphorylation of eIF-2α may attenuate ER 
stress for adaptation to increased ER protein load. The use of 
sulfonylurea in type 2 diabetes may not be the direct cause of 
secondary β-cell failure. To evaluate the results, further well-
designed studies using various types of cell lines and sulfonyl-
ureas will be necessary to elucidate a more detailed mechanism.
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